{"name":"Aquestive Therapeutics","slug":"aquestive-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNUEd6bmFmQWExTlVkNEhNcXFlLVEyem84bVZKT1ZxdXFlbDNuN3FhU1BzWE9hWU5Ja19PZEw3ZDJIWlV0S1NHRFBCVlJSV1NWODJ0M3Zhb2tQUWJpYUVnYk5qS05YYlZ2T2ExNjgwdmRyNkMwNndzbmpFQ1VieWp4YTRGSEFkek9xNjhrUFdWR0ctNE9UdGt1MjF2dTcxa2tQV3ZLTnJ3aWZhclNiTjRwZVBxX0g3NlVaVUFaT0NlOVlrTG1QcFFaMmx3NkFiSlVKWFJiY3FTX1RVLVg1ZHJVSFVYNU1MSS1pc01NOFE2NVZhZHhVVDUxZTVKWmU0SEVWVG9hRW10T3lZZVhLQ1kzODR2T0Z4QncyaGFyVWlNTzdzcWpMMTRUbU9kUU1xVm56VnE0cGVxNzRLQlA5aGdJYmoxbnNUQ3BmWXRJ?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharma, SK Biopharma - Barc","headline":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aques","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-04-03","type":"regulatory","source":"MSN","summary":"Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN","headline":"Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQdjJ5SUR0cFRlek9tMHRYQlBmbVRlM3dIWmh3NGtuMmtXZTdRUzVweXhrWGNVc1hiQkVWODFqS241bTVxNHN3cklodUd2TjBDZnloN3hwYWxZNWplb0hQaVpRN0NqRVFBQkF2Zk1EUVViOHJFN2w1ZVk4U0VieTMza0ZBTXIxSVkzaWhzOXA5UHZ3QWVWeU1RcWJhS3doWndiNWhLUVZSbFpaMnVPUWRaOUV3Mm1TR28yUS1HLV81cHJrdExo?oc=5","date":"2026-03-30","type":"regulatory","source":"Investing News Network","summary":"Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm Sublingual Film - Investing News Network","headline":"Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm Sublingual Film","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-05","type":"pipeline","source":"simplywall.st","summary":"Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely - simplywall.st","headline":"Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOVFZyNUVKbFc2LXUxYWE2VVVCRl9mXzJXdWh4VENUTE1IWU54LWtCcjZYb2pLdVZnbjRsVmdINDBDbkpWRndVU252ZmUxSDZoSWN6TmM5TTJCUWcwRjBBLWpxUnE1V2k3dmMtNUZHajhzbnJCM2FfLW5aa0xFQ3hnSk9HZFA0Y1N0czhIWXV2Z3RwZllQLWtjSnV5ZTZETzI5bFp4aURkM0NhSnRiZmdxMHNON3dtR2s3U3RvdmV6LWRxRGZmRnVkY1NDTFZkQXc1?oc=5","date":"2026-02-02","type":"regulatory","source":"reuters.com","summary":"US FDA declines to approve Aquestive's oral drug for allergic reactions - reuters.com","headline":"US FDA declines to approve Aquestive's oral drug for allergic reactions","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOSDBBeEZxUWlQRmV6NmtweEU5bXNNdXBuS1RFMEx3TlN4OHJibGVvZjlsY3B4NHYycWRHVmZNMTIzZjRjdUxBRHJOTUxLXzY5TWZxb3A2MGVXb0ZISzU1d0VYQzRrWHVjbzBJUHdMempwck4xdS10bU8xdjh1bUpLZ0paeFBWb2h5VHlOallqQmlMNDJETFNUaW9hdw?oc=5","date":"2026-02-02","type":"regulatory","source":"Fierce Pharma","summary":"With FDA rejections, Aquestive's shares go up, while Pharming's go down - Fierce Pharma","headline":"With FDA rejections, Aquestive's shares go up, while Pharming's go down","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB4b2s5VmpLd0o5RDZzQ2hISmJwVVdEdF82QVNaX0NUU2V0UGxwYmRPbjAwRUctdG4yN1BIOHM1NDJEbnF0SkNreWw0Z2JJSHJKd3o4?oc=5","date":"2026-02-02","type":"regulatory","source":"FirstWord Pharma","summary":"FDA knock-backs send shares in Pharming down, Aquestive up - FirstWord Pharma","headline":"FDA knock-backs send shares in Pharming down, Aquestive up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQTlp4bXF4ZnJMbndrRnI0dWZpTDBQa0xrcEYzTVg5RDRobHJFZEpPYk9YS2hqejhjMFJvU0JWdng4bXJTcGhnbkRCQ1dOdEw1QnEzaU1EWFlkdUZBamZzSTZIQUJ6RjMzaUJJSkVXcFhSaDRQd0NIQXAwR0QtVU10cXhlQlJnbXpHUGVmaTFJcF9mamFkeE83WHBoZXA0bzA4Q2pRTS03RDVVRF9yQjZjYW55aU1vMHpULTFYblJ1MjhjUG93SjNkU2d6SFRpN1d6VU16ZHo5blZIZmtILUxJczlNWUN0Nlo1dXRpU2ZXVQ?oc=5","date":"2026-02-02","type":"regulatory","source":"globenewswire.com","summary":"Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™ - globenewswire.com","headline":"Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQa3RXLVliVGktdHZhUFRad1RpdWdyWDlMNkNjQ211ZGpqQlJkZHJtUElVMW00N0JYbDdfS21NWGkyYjgwb1Q3bGlJU2lnZlFYTUNfSjNLbE1GVzJObF92TlZqWkc5RWVmVlZya3BRZHRVdWpQTmVjQmxJeXpfZVRaX3Q2VHEtM19TLTNpYUlrTFEzS0N1TnktRGliMkdrdlk?oc=5","date":"2026-02-02","type":"pipeline","source":"The Pharma Letter","summary":"Aquestive leaps, despite receiving CRL for Anaphylm NDA - The Pharma Letter","headline":"Aquestive leaps, despite receiving CRL for Anaphylm NDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOamViRE9DdS1WMDJJOXZnNHhzWVNGb2ZCX3FhdUFPTE9TdGlFaE5zQjhkaDkxcEhDaGc0M0xBRVl4ektXemJ0MzNYT19NTUctVXNxWjQ5eF9GUVBKQTlUSXBCWVJUbzY1SnYzMWp6RWg1MHdibjgxYzkwTURMT2xYQURCLXNSbXdjUVNPa0tnMWRfQkNKejhlNHByQUVpVENVUHVIRmo2eGVnN3I0OEdOZkQzZFRuYWJSekMyQ081ZXYzTmp3NkQzb0pvMDRFVjAtRXBRTWVpUEVCTlpBRFZOWUdPb042bWdGRk5pWNIB8gFBVV95cUxQWXNmS1prX3ltYXZRRTJHVHp3VHZJckE0cnJsVjNicXNudDFOZE5lc0g3SzBsb1BqMmluOWdKNnBMNFFmR21OZjdUWGV1WG9nZTR4MnI4QWFfRzJlX0RucTQyNTVLc0c2elhGRThzS2RENlZBWFE1YWNrWHczYjdmVUE0N1RrUEJJd0NFVnRraHBWUndtc3dCeHBwR0pkRVJuVFExZjRfcVBzMHRtNXlqZHNCZW1NOHZ2VHpBT1g4cGxSVHdIS1Y1T2VIVXlWQU04bzEtdGZJS0dQWnZVdm82YUNqcGwxeEliQ3dBT1Z3QkEyQQ?oc=5","date":"2026-01-11","type":"regulatory","source":"simplywall.st","summary":"Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies in Anaphylm Filing - What's Changed - simplywall.st","headline":"Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies in Anaphylm Filing - What's Changed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNcDRudXVwSFRSZ3RWR2VELVdLYXYzWGVUNVBnMGlOSEZmVjNlWldfVFdyWFFVUkxCbGpGamJjT0VGbTdibk5SWTF2SmUtR0tvdDRLZ2VkXzU4dEhvQ3pUMXJka3RYUFB5ZUZueENoX21feTlvQzFBeVg4dkhhcVdUZzZUTTllZEJzbHFaT0hlSEFCbjBRNDNBSzZvNDNzN3JLNVpuQTNTTUhaTkxBbGl0WWpNTmx0RjBuWFFrUk5YZnFNOVdidjdmWHlqaTVtbVFER1ZDZVZzcXJZZERVMFZQWElDUDB6TkV0eVh6NE5MYmpuWWZoTjdyRlV0OVR1TExLVlB4S2tUZlVDcGphMEgyVV84aEd1N3hmMzZFWVJFeUw3SjIwellXTEpR?oc=5","date":"2026-01-09","type":"regulatory","source":"globenewswire.com","summary":"Aquestive Therapeutics Announces Regulatory Development for - globenewswire.com","headline":"Aquestive Therapeutics Announces Regulatory Development for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOajFOU0MzbTlUSnRoTENaUndLRWxLUm92WGhkM3JpazdGMGFOTnE0c0R6djNaLVM4aGFQYVpwOXNIR0RUT2J1UGVEUTdJSV9hZU9qQ210ZG56SlI5UV9BeGMyRDJXNjgtbXVFaVdTLVlJVVEtRVk1NGNnalJvalZ4YWxRRU9YTGFQQlpLampBdw?oc=5","date":"2026-01-09","type":"regulatory","source":"The Pharma Letter","summary":"FDA setback for Aquestive Thera’s Anaphylm - The Pharma Letter","headline":"FDA setback for Aquestive Thera’s Anaphylm","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}